Clinician practices and attitudes regarding early antiretroviral therapy in the United States

Ann E. Kurth, Kenneth Mayer, Geetha Beauchamp, Laura McKinstry, Jennifer Farrior, Kate Buchacz, Deborah Donnell, Bernard Branson, Wafaa El-Sadr

Research output: Contribution to journalArticle

Abstract

Background: Use of antiretroviral therapy (ART) to prevent HIV transmission has received substantial attention after a recent trial demonstrating efficacy of ART to reduce HIV transmission in HIV-discordant couples. Objective: To assess practices and attitudes of HIV clinicians regarding early initiation of ART for treatment and prevention of HIV at sites participating in the HIV Prevention Trials Network 065 study. Design: Cross-sectional internet-based survey. Methods: ART-prescribing clinicians (n = 165 physicians, nurse practitioners, physician assistants) at 38 HIV care sites in Bronx, NY, and Washington, DC, completed a brief anonymous Internet survey, before any participation in the HIV Prevention Trials Network 065 study. Analyses included associations between clinician characteristics and willingness to prescribe ART for prevention. Results: Almost all respondents (95%), of whom 59% were female, 66% white, and 77% HIV specialists, "strongly agreed/agreed" that early ART can decrease HIV transmission. Fifty-six percent currently recommend ART initiation for HIV-infected patients with CD4+ count <500 cells per cubic millimeter, and 14% indicated that they initiate ART irrespective of CD4+ count. Most (75%) indicated that they would consider initiating ART earlier than otherwise indicated for patients in HIV-discordant sexual partnerships, and 40% would do so if a patient was having unprotected sex with a partner of unknown HIV status. There were no significant differences by age, gender, or clinician type in likelihood of initiating ART for reasons including HIV transmission prevention to sexual partners. Conclusions: This sample of US clinicians indicated support for early ART initiation to prevent HIV transmission, especially for situations where such transmission would be more likely to occur.

Original languageEnglish (US)
JournalJournal of Acquired Immune Deficiency Syndromes
Volume61
Issue number5
DOIs
StatePublished - Dec 15 2012

Fingerprint

Secondary Prevention
HIV
Therapeutics
CD4 Lymphocyte Count
Internet
Unsafe Sex
Physician Assistants
Nurse Practitioners
Sexual Partners

Keywords

  • Clinician survey
  • Early antiretroviral therapy
  • HIV prevention
  • Test and treat

ASJC Scopus subject areas

  • Infectious Diseases
  • Pharmacology (medical)
  • Medicine(all)

Cite this

Clinician practices and attitudes regarding early antiretroviral therapy in the United States. / Kurth, Ann E.; Mayer, Kenneth; Beauchamp, Geetha; McKinstry, Laura; Farrior, Jennifer; Buchacz, Kate; Donnell, Deborah; Branson, Bernard; El-Sadr, Wafaa.

In: Journal of Acquired Immune Deficiency Syndromes, Vol. 61, No. 5, 15.12.2012.

Research output: Contribution to journalArticle

Kurth, AE, Mayer, K, Beauchamp, G, McKinstry, L, Farrior, J, Buchacz, K, Donnell, D, Branson, B & El-Sadr, W 2012, 'Clinician practices and attitudes regarding early antiretroviral therapy in the United States', Journal of Acquired Immune Deficiency Syndromes, vol. 61, no. 5. https://doi.org/10.1097/QAI.0b013e31826a184c
Kurth, Ann E. ; Mayer, Kenneth ; Beauchamp, Geetha ; McKinstry, Laura ; Farrior, Jennifer ; Buchacz, Kate ; Donnell, Deborah ; Branson, Bernard ; El-Sadr, Wafaa. / Clinician practices and attitudes regarding early antiretroviral therapy in the United States. In: Journal of Acquired Immune Deficiency Syndromes. 2012 ; Vol. 61, No. 5.
@article{43f0cb204c2741fc8c9eccdba9c842c2,
title = "Clinician practices and attitudes regarding early antiretroviral therapy in the United States",
abstract = "Background: Use of antiretroviral therapy (ART) to prevent HIV transmission has received substantial attention after a recent trial demonstrating efficacy of ART to reduce HIV transmission in HIV-discordant couples. Objective: To assess practices and attitudes of HIV clinicians regarding early initiation of ART for treatment and prevention of HIV at sites participating in the HIV Prevention Trials Network 065 study. Design: Cross-sectional internet-based survey. Methods: ART-prescribing clinicians (n = 165 physicians, nurse practitioners, physician assistants) at 38 HIV care sites in Bronx, NY, and Washington, DC, completed a brief anonymous Internet survey, before any participation in the HIV Prevention Trials Network 065 study. Analyses included associations between clinician characteristics and willingness to prescribe ART for prevention. Results: Almost all respondents (95{\%}), of whom 59{\%} were female, 66{\%} white, and 77{\%} HIV specialists, {"}strongly agreed/agreed{"} that early ART can decrease HIV transmission. Fifty-six percent currently recommend ART initiation for HIV-infected patients with CD4+ count <500 cells per cubic millimeter, and 14{\%} indicated that they initiate ART irrespective of CD4+ count. Most (75{\%}) indicated that they would consider initiating ART earlier than otherwise indicated for patients in HIV-discordant sexual partnerships, and 40{\%} would do so if a patient was having unprotected sex with a partner of unknown HIV status. There were no significant differences by age, gender, or clinician type in likelihood of initiating ART for reasons including HIV transmission prevention to sexual partners. Conclusions: This sample of US clinicians indicated support for early ART initiation to prevent HIV transmission, especially for situations where such transmission would be more likely to occur.",
keywords = "Clinician survey, Early antiretroviral therapy, HIV prevention, Test and treat",
author = "Kurth, {Ann E.} and Kenneth Mayer and Geetha Beauchamp and Laura McKinstry and Jennifer Farrior and Kate Buchacz and Deborah Donnell and Bernard Branson and Wafaa El-Sadr",
year = "2012",
month = "12",
day = "15",
doi = "10.1097/QAI.0b013e31826a184c",
language = "English (US)",
volume = "61",
journal = "Journal of Acquired Immune Deficiency Syndromes",
issn = "1525-4135",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Clinician practices and attitudes regarding early antiretroviral therapy in the United States

AU - Kurth, Ann E.

AU - Mayer, Kenneth

AU - Beauchamp, Geetha

AU - McKinstry, Laura

AU - Farrior, Jennifer

AU - Buchacz, Kate

AU - Donnell, Deborah

AU - Branson, Bernard

AU - El-Sadr, Wafaa

PY - 2012/12/15

Y1 - 2012/12/15

N2 - Background: Use of antiretroviral therapy (ART) to prevent HIV transmission has received substantial attention after a recent trial demonstrating efficacy of ART to reduce HIV transmission in HIV-discordant couples. Objective: To assess practices and attitudes of HIV clinicians regarding early initiation of ART for treatment and prevention of HIV at sites participating in the HIV Prevention Trials Network 065 study. Design: Cross-sectional internet-based survey. Methods: ART-prescribing clinicians (n = 165 physicians, nurse practitioners, physician assistants) at 38 HIV care sites in Bronx, NY, and Washington, DC, completed a brief anonymous Internet survey, before any participation in the HIV Prevention Trials Network 065 study. Analyses included associations between clinician characteristics and willingness to prescribe ART for prevention. Results: Almost all respondents (95%), of whom 59% were female, 66% white, and 77% HIV specialists, "strongly agreed/agreed" that early ART can decrease HIV transmission. Fifty-six percent currently recommend ART initiation for HIV-infected patients with CD4+ count <500 cells per cubic millimeter, and 14% indicated that they initiate ART irrespective of CD4+ count. Most (75%) indicated that they would consider initiating ART earlier than otherwise indicated for patients in HIV-discordant sexual partnerships, and 40% would do so if a patient was having unprotected sex with a partner of unknown HIV status. There were no significant differences by age, gender, or clinician type in likelihood of initiating ART for reasons including HIV transmission prevention to sexual partners. Conclusions: This sample of US clinicians indicated support for early ART initiation to prevent HIV transmission, especially for situations where such transmission would be more likely to occur.

AB - Background: Use of antiretroviral therapy (ART) to prevent HIV transmission has received substantial attention after a recent trial demonstrating efficacy of ART to reduce HIV transmission in HIV-discordant couples. Objective: To assess practices and attitudes of HIV clinicians regarding early initiation of ART for treatment and prevention of HIV at sites participating in the HIV Prevention Trials Network 065 study. Design: Cross-sectional internet-based survey. Methods: ART-prescribing clinicians (n = 165 physicians, nurse practitioners, physician assistants) at 38 HIV care sites in Bronx, NY, and Washington, DC, completed a brief anonymous Internet survey, before any participation in the HIV Prevention Trials Network 065 study. Analyses included associations between clinician characteristics and willingness to prescribe ART for prevention. Results: Almost all respondents (95%), of whom 59% were female, 66% white, and 77% HIV specialists, "strongly agreed/agreed" that early ART can decrease HIV transmission. Fifty-six percent currently recommend ART initiation for HIV-infected patients with CD4+ count <500 cells per cubic millimeter, and 14% indicated that they initiate ART irrespective of CD4+ count. Most (75%) indicated that they would consider initiating ART earlier than otherwise indicated for patients in HIV-discordant sexual partnerships, and 40% would do so if a patient was having unprotected sex with a partner of unknown HIV status. There were no significant differences by age, gender, or clinician type in likelihood of initiating ART for reasons including HIV transmission prevention to sexual partners. Conclusions: This sample of US clinicians indicated support for early ART initiation to prevent HIV transmission, especially for situations where such transmission would be more likely to occur.

KW - Clinician survey

KW - Early antiretroviral therapy

KW - HIV prevention

KW - Test and treat

UR - http://www.scopus.com/inward/record.url?scp=84873110238&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84873110238&partnerID=8YFLogxK

U2 - 10.1097/QAI.0b013e31826a184c

DO - 10.1097/QAI.0b013e31826a184c

M3 - Article

VL - 61

JO - Journal of Acquired Immune Deficiency Syndromes

JF - Journal of Acquired Immune Deficiency Syndromes

SN - 1525-4135

IS - 5

ER -